Neuland Laboratories Ltd.
₹12,825-2.87%Feb 27, 3:45 PM IST
NEULANDLAB•Health Technology•Pharmaceuticals: Major
Current Price
₹12,825-2.87%
Feb 27, 3:45 PM ISTMarket Cap₹16,950.59 Cr
Market Cap₹16,950.59 Cr
Business Overview
Neuland Laboratories Limited operates through 2 main business divisions including Generic Drug Substances (GDS), Custom Manufacturing Solutions (CMS).
Business Hierarchy Structure for Neuland Laboratories Limited
- Neuland Laboratories Limited
- Generic Drug Substances (GDS)
- Prime APIs
- Mirtazapine
- Escitalopram
- Specialty APIs
- Paliperidone Palmitate
- Salmeterol
- Apixaban
- Paliperidone
- Brinzolamide
- Dorzolamide
- Deferasirox
- Donepezil
- Entacapone
- Salmeterol
- Prime APIs
- Custom Manufacturing Solutions (CMS)
- New Chemical Entity (NCE) APIs
- Small Molecule API Development & Manufacturing
- Process Chemistry Services
- cGMP Manufacturing of APIs
- CMC Documentation/DMF Filing
- Solid-State and Pre-formulation Technologies
- Pre-IND Services
- Clinical Trial Supplies
- Commercial Supplies
- Contract Research Services
- Generic Drug Substances (GDS)